These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9179161)

  • 21. Variability of presentation in hereditary neuropathy with liability to pressure palsy results in underrecognition.
    Kumar N; Cole J; Parry GJ
    Ann N Y Acad Sci; 1999 Sep; 883():344-50. PubMed ID: 10586259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of real-time quantitative PCR compare to repeat PCR for the diagnosis of Charcot-Marie-Tooth Type 1A and hereditary neuropathy with liability to pressure palsies.
    Choi JR; Lee WH; Sunwoo IN; Lee EK; Lee CH; Lim JB
    Yonsei Med J; 2005 Jun; 46(3):347-52. PubMed ID: 15988805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary neuropathy with liability to pressure palsy (HNPP) in childhood: a case study emphasizing the relevance of detailed electrophysiological examination for suspected HNPP in the first decade.
    Bayrak AO; Battaloglu E; Turker H; Baris I; Oztas G
    Brain Dev; 2009 Jun; 31(6):445-8. PubMed ID: 18760885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hereditary neuropathy with liability to pressure palsy].
    Eisenberg E; Baron S; Ludicer R
    Harefuah; 1989 Apr; 116(7):345-7. PubMed ID: 2737556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A gait disorder caused by hereditary motor-sensory neuropathy].
    Sauter R
    Z Orthop Ihre Grenzgeb; 1990; 128(2):123-7. PubMed ID: 2140641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between PMP-22 messenger RNA expression and phenotype in hereditary neuropathy with liability to pressure palsies.
    Schenone A; Nobbio L; Caponnetto C; Abbruzzese M; Mandich P; Bellone E; Ajmar F; Gherardi G; Windebank AJ; Mancardi G
    Ann Neurol; 1997 Dec; 42(6):866-72. PubMed ID: 9403478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comments on 'hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large Chinese family'.
    Delacour H; Bousquet A; Bugier S; Ceppa F
    Eur Neurol; 2013; 70(5-6):364. PubMed ID: 24192759
    [No Abstract]   [Full Text] [Related]  

  • 28. Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy.
    Chance PF
    Neuromolecular Med; 2006; 8(1-2):159-74. PubMed ID: 16775374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and electrophysiologic features of HNPP patients with 17p11.2 deletion.
    Hong YH; Kim M; Kim HJ; Sung JJ; Kim SH; Lee KW
    Acta Neurol Scand; 2003 Nov; 108(5):352-8. PubMed ID: 14616306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural PMP22 expression in inherited demyelinating neuropathies.
    Vallat JM; Sindou P; Preux PM; Tabaraud F; Milor AM; Couratier P; LeGuern E; Brice A
    Ann Neurol; 1996 Jun; 39(6):813-7. PubMed ID: 8651657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncompacted myelin in hereditary neuropathy with liability to pressure palsies with the 17 p11.2 deletion.
    Jedrzejowska H; Fidziańska A; Kochański A
    Folia Neuropathol; 1999; 37(4):220-6. PubMed ID: 10705641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inherited primary peripheral neuropathies. Molecular genetics and clinical implications of CMT1A and HNPP.
    Lupski JR; Chance PF; Garcia CA
    JAMA; 1993 Nov; 270(19):2326-30. PubMed ID: 8230595
    [No Abstract]   [Full Text] [Related]  

  • 33. Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
    Potulska-Chromik A; Ryniewicz B; Aragon-Gawinska K; Kabzinska D; Seroka A; Lipowska M; Kaminska AM; Kostera-Pruszczyk A
    J Peripher Nerv Syst; 2016 Mar; 21(1):22-6. PubMed ID: 26663344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inherited peripheral neuropathy.
    Keller MP; Chance PF
    Semin Neurol; 1999; 19(4):353-62. PubMed ID: 10716658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory.
    Shaffer LG; Kennedy GM; Spikes AS; Lupski JR
    Am J Med Genet; 1997 Mar; 69(3):325-31. PubMed ID: 9096765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PMP-22 gene duplications and deletions identified in archival, paraffin-embedded sural nerve biopsy specimens: correlation to structural changes.
    Thiex R; Schröder JM
    Acta Neuropathol; 1998 Jul; 96(1):13-21. PubMed ID: 9678509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular diagnosis of PMP22-associated neuropathies using fluorescence in situ hybridization (FISH) on archival peripheral nerve tissue preparations.
    Liehr T; Grehl H; Rautenstrauss B
    Acta Neuropathol; 1997 Sep; 94(3):266-71. PubMed ID: 9292696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European descent.
    Timmerman V; Rautenstrauss B; Reiter LT; Koeuth T; Löfgren A; Liehr T; Nelis E; Bathke KD; De Jonghe P; Grehl H; Martin JJ; Lupski JR; Van Broeckhoven C
    J Med Genet; 1997 Jan; 34(1):43-9. PubMed ID: 9032649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
    Bird TD; Kraft GH; Lipe HP; Kenney KL; Sumi SM
    Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allele-specific all-or-none PCR product diagnostic strategy for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies.
    Lin KP; Chou CH; Lee HY; Soong BW
    J Chin Med Assoc; 2006 Feb; 69(2):68-73. PubMed ID: 16570573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.